Imperato-McGinley, Julianne

Publications

Sort by

Co-Author Network

selected publications

Effective Low-Cost Ophthalmological Screening With a Novel iPhone Fundus Camera at Community Centers. Cureus. 2022 Academic Article GET IT
Social and Clinical Determinants of COVID-19 Outcomes: Modeling Real-World Data from a Pandemic Epicenter. medRxiv : the preprint server for health sciences. 2021 Article GET IT
Dual action of NSC606985 on cell growth and apoptosis mediated through PKCδ in prostatic cancer cells. International journal of oncology. 2017 Academic Article GET IT
Times cited: 4
Dissociation of NSC606985 induces atypical ER-stress and cell death in prostate cancer cells. International journal of oncology. 2016 Academic Article GET IT
Times cited: 6
The effect of 5α-reductase-2 deficiency on human fertility. Fertility and sterility. 2014 Review GET IT
Times cited: 64
Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium. Clinical and translational science. 2013 Academic Article GET IT
Times cited: 18
Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells. The Prostate. 2013 Academic Article GET IT
Times cited: 14
Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells. International journal of oncology. 2012 Academic Article GET IT
Times cited: 12
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clinical and translational science. 2012 Academic Article GET IT
Times cited: 14
The first successful paternity through in vitro fertilization-intracytoplasmic sperm injection with a man homozygous for the 5α-reductase-2 gene mutation. 2011 GET IT
Times cited: 22
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. American journal of physiology. Heart and circulatory physiology. 2011 Academic Article GET IT
Times cited: 67
Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer. The Journal of urology. 2011 Academic Article GET IT
Times cited: 10
5alpha-reductase isozymes and androgen actions in the prostate. Annals of the New York Academy of Sciences. 2009 Review GET IT
Times cited: 73
NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells. Cancer chemotherapy and pharmacology. 2008 Academic Article GET IT
Times cited: 19
17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals. The Prostate. 2007 Academic Article GET IT
Times cited: 11
Sex specificity of ventral anterior cingulate cortex suppression during a cognitive task. Human brain mapping. 2007 Academic Article GET IT
Times cited: 18
Gender differences in object location memory: a meta-analysis. Psychonomic bulletin & review. 2007 Review GET IT
Times cited: 184
The relation between computerized and paper-and-pencil mental rotation tasks: a validation study. Journal of clinical and experimental neuropsychology. 2006 Academic Article GET IT
Times cited: 45
Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. The Journal of clinical endocrinology and metabolism. 2006 Academic Article GET IT
Times cited: 89
Sex differences in mental rotation: top-down versus bottom-up processing. NeuroImage. 2006 Academic Article GET IT
Times cited: 108
Regulation of prostate 5alpha-reductase-2 gene expression and prostate weight by dietary fat and caloric intake in the rat. The Prostate. 2006 Academic Article GET IT
Times cited: 17
Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens. Journal of andrology. 2005 Academic Article GET IT
Times cited: 25
Fetal hormones and sexual differentiation. Obstetrics and gynecology clinics of North America. 2004 Review GET IT
Times cited: 31
Long-term growth hormone therapy in adulthood results in significant linear growth in siblings with a PROP-1 gene mutation. The Journal of clinical endocrinology and metabolism. 2004 Academic Article GET IT
Times cited: 4
Gender identity in XY intersexuality. Child and adolescent psychiatric clinics of North America. 2004 Review GET IT
Times cited: 29
Mutations in CYP11B1 gene: phenotype-genotype correlations. 2003 GET IT
Times cited: 33
Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells. Journal of andrology. 2003 Academic Article GET IT
Times cited: 44
The Chinese medicinal herbal formula ZYD88 inhibits cell growth and promotes cell apoptosis in prostatic tumor cells. Oncology reports. 2003 Academic Article GET IT
Times cited: 10
Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Molecular and cellular endocrinology. 2002 Review GET IT
Times cited: 230
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology. 2002 Academic Article GET IT
Times cited: 70
The effect of finasteride in men with benign prostatic hyperplasia. 1992. The Journal of urology. 2002 Review GET IT
Times cited: 37
5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Advances in experimental medicine and biology. 2002 Review GET IT
Times cited: 48
Molecular analysis of estrogen induction of preproenkephalin gene expression and its modulation by thyroid hormones. Brain research. Molecular brain research. 2001 Academic Article GET IT
Times cited: 29
Testicular position in the androgen insensitivity syndrome: implications for the role of androgens in testicular descent. The Journal of urology. 2000 Review GET IT
Times cited: 66
Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. Journal of pediatric endocrinology & metabolism : JPEM. 2000 Academic Article GET IT
Times cited: 44
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. Journal of the American Academy of Dermatology. 1999 Academic Article GET IT
Times cited: 100
A novel mutation in the CAG triplet region of exon 1 of androgen receptor gene causes complete androgen insensitivity syndrome in a large kindred. The Journal of clinical endocrinology and metabolism. 1999 Academic Article GET IT
Times cited: 31
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Journal of the American Academy of Dermatology. 1998 Academic Article GET IT
Times cited: 575
A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. 1998 GET IT
Times cited: 84
Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance. 1998 GET IT
Times cited: 29
Natural potent androgens: lessons from human genetic models. Bailliere's clinical endocrinology and metabolism. 1998 Review GET IT
Times cited: 40
The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. The Journal of clinical endocrinology and metabolism. 1998 Academic Article GET IT
Times cited: 73
Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. 1997 GET IT
Times cited: 98
Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clinical endocrinology. 1997 Academic Article GET IT
Times cited: 63
5 alpha-reductase activity and prostate cancer: a case-control study using stored sera. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1997 Academic Article GET IT
Times cited: 50
5 alpha-reductase-2 deficiency. Current therapy in endocrinology and metabolism. 1997 Review GET IT
Times cited: 36
5 alpha-reductase-2 gene mutations in the Dominican Republic. 1996 GET IT
Times cited: 62
The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency. 1995 GET IT
Times cited: 49
Male pseudohermaphroditism due to primary 5 alpha-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees. Journal of endocrinological investigation. 1995 Academic Article GET IT
Times cited: 38
Proscar: five-year experience. European urology. 1995 Academic Article GET IT
Times cited: 63
Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency. The Journal of clinical endocrinology and metabolism. 1994 Academic Article GET IT
Times cited: 52
Luteinizing hormone pulsatility in subjects with 5-alpha-reductase deficiency and decreased dihydrotestosterone production. The Journal of clinical endocrinology and metabolism. 1994 Academic Article GET IT
Times cited: 22
5 alpha-reductase deficiency: human and animal models. European urology. 1994 Academic Article GET IT
Times cited: 15
5-alpha-reductase deficiency. Current therapy in endocrinology and metabolism. 1994 Academic Article GET IT
Times cited: 7
Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy. Progress in clinical and biological research. 1994 Review GET IT
Times cited: 4
Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection. Progress in clinical and biological research. 1994 Review GET IT
Times cited: 3
Studies of the hormonal control of postnatal testicular descent in the rat. The Journal of urology. 1993 Academic Article GET IT
Times cited: 24
The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. The Journal of clinical endocrinology and metabolism. 1993 Academic Article GET IT
Times cited: 194
Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 113
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. The New England journal of medicine. 1992 Academic Article GET IT
Times cited: 982
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency. The Journal of clinical endocrinology and metabolism. 1992 Academic Article GET IT
Times cited: 139
Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology. 1992 Academic Article GET IT
Times cited: 213
Molecular genetics of steroid 5 alpha-reductase 2 deficiency. The Journal of clinical investigation. 1992 Academic Article GET IT
Times cited: 352
The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group. The Journal of urology. 1992 Academic Article GET IT
Times cited: 141
Complete androgen insensitivity Pathophysiology, diagnosis, and management. Trends in endocrinology and metabolism: TEM. 1992 Academic Article GET IT
Times cited: 11
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. The Journal of clinical investigation. 1992 Academic Article GET IT
Times cited: 375
A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. 1991 GET IT
Times cited: 87
Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5 alpha-reductase inhibitor. Steroids. 1991 Academic Article GET IT
Times cited: 28
Effects of flutamide and finasteride on rat testicular descent. Endocrinology. 1991 Academic Article GET IT
Times cited: 123
Cognitive abilities in androgen-insensitive subjects: comparison with control males and females from the same kindred. Clinical endocrinology. 1991 Academic Article GET IT
Times cited: 70
A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clinical endocrinology. 1991 Academic Article GET IT
Times cited: 132
5 alpha-metabolism in finasteride-treated subjects and male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. A review. European urology. 1991 Academic Article GET IT
Times cited: 8
Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin. 1990 GET IT
Times cited: 54
DNA linkage analysis and studies of the androgen receptor gene in a large kindred with complete androgen insensitivity. American journal of medical genetics. 1990 Academic Article GET IT
Times cited: 20
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency. The Journal of clinical endocrinology and metabolism. 1990 Academic Article GET IT
Times cited: 54
Decreased 3 alpha-androstanediol glucuronide levels in plasma and random urines in male pseudohermaphroditism caused by 5 alpha-reductase deficiency. Metabolism: clinical and experimental. 1989 Academic Article GET IT
Times cited: 10
The coexistence of male pseudohermaphrodites with 17-ketosteroid reductase deficiency and 5 alpha-reductase deficiency within a Turkish kindred. 1987 GET IT
Times cited: 19
Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. 1987 GET IT
Times cited: 166
The diagnosis of 5 alpha-reductase deficiency in infancy. 1986 GET IT
Times cited: 67
The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic. The Journal of urology. 1986 Academic Article GET IT
Times cited: 18
Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village. The American journal of medicine. 1986 Academic Article GET IT
Times cited: 53
Late-onset 21-hydroxylase deficiency: reliable diagnosis by steroid analysis of random urine collections. 1986 GET IT
Times cited: 8
Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5 alpha-reductase: definition of a selective role for dihydrotestosterone. Endocrinology. 1986 Academic Article GET IT
Times cited: 42
Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. 1985 GET IT
Times cited: 113
Urinary steroid metabolites in subjects with male pseudohermaphroditism due to 5 alpha-reductase deficiency. Clinical endocrinology. 1985 Academic Article GET IT
Times cited: 37
Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers. The Journal of clinical endocrinology and metabolism. 1985 Academic Article GET IT
Times cited: 45
The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase. Endocrinology. 1985 Academic Article GET IT
Times cited: 91
Remission of Cushing's syndrome during pregnancy. 1983 GET IT
Times cited: 14
Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. The Journal of clinical endocrinology and metabolism. 1982 Academic Article GET IT
Times cited: 107
Testosterone secreting adrenal cortical adenomas. 1981 GET IT
Times cited: 11
Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. 1981 GET IT
Times cited: 52
Steroid hormone secretion from a virilizing lipoid cell tumor of the ovary. 1981 GET IT
Times cited: 24
Steroid 5 alpha-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity. 1980 GET IT
Times cited: 81
Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. 1979 GET IT
Times cited: 84
Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. Journal of steroid biochemistry. 1979 Academic Article GET IT
Times cited: 114
Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. The New England journal of medicine. 1979 Academic Article GET IT
Times cited: 352
Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. 1978 GET IT
Times cited: 87
Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. 1978 GET IT
Times cited: 55
Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. The American journal of medicine. 1977 Academic Article GET IT
Times cited: 298
Male pseudohermaphroditism: the complexities of male phenotypic development. The American journal of medicine. 1976 Review GET IT
Times cited: 114
Letter: Gender identity and hermaphroditism. Science (New York, N.Y.). 1976 Academic Article GET IT
Times cited: 21
Cortisol metabolism in the perinatal period. Progress in clinical and biological research. 1976 Academic Article GET IT
Times cited: 10
Steroid 5alpha-reductase deficiency in man. An inherited form of male pseudohermaphroditism. Birth defects original article series. 1975 Academic Article GET IT
Times cited: 21
Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science (New York, N.Y.). 1974 Academic Article GET IT
Times cited: 1043

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Clinical and Translational Science Center - UL1 awarded by National Center for Advancing Translational Sciences Principal Investigator 2022 - 2027
Clinical and Translational Science Center- Institutional CTSC Internal Funding UL1 awarded by CTSC Cost Share Principal Investigator 2022 - 2027

Research Training in Endocrinology and Metabolism awarded by National Institute of Diabetes & Digestive & Kidney Diseases Key Personnel 2023 - 2028

more ...

less ...

Background

education and training

M.D., State University of New York Health Science Center at Brooklyn 1965
B.S., College of Mount St. Vincent 1961

Contact

full name

Julianne Imperato-McGinley

primary email

jimperat@med.cornell.edu

VIVO Weill Cornell Medical College

Julianne Imperato-McGinley Professor of Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email